On April 24, 2023, J. Paul McClaskey, Senior Vice President, Chief Accounting Officer of PhenomeX Inc. (the Company), notified the Company he is resigning to pursue other opportunities, effective June 2, 2023 (the Effective Date). In connection with Mr. McClaskey's resignation, Mehul Joshi, Chief Financial Officer of the Company, will serve as the Company's principal accounting officer effective as of the Effective Date. No new compensatory agreements were entered into with Mr. Joshi in connection with his serving as principal accounting officer.
Bruker Cellular Analysis, Inc.
Equities
BLI
US0843101017
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+32.49% | 49.46B | |
+1.57% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.78% | 26.61B | |
-22.83% | 18.64B | |
+7.95% | 13.16B | |
+30.33% | 12.55B | |
+24.13% | 12.1B |